Shanghai Nanmu Biological Technology Co., Ltd. (SHA: 688265): Wang Jinjin, employee representative director, plans to sell no more than 2,500 shares.

Gelonghui, June 2 — Nanmu Biology (SHA: 688265) announced that Ms. Wang Jinjin, an employee representative director of the company, intends to reduce her holdings of the company's shares by no more than 2,500 shares, representing no more than 0.0032% of the company’s total share capital, through centralized bidding transactions due to personal funding requirements. The reduction will take place within three months starting from the 15th trading day following the disclosure of this announcement (excluding periods during which share reductions are prohibited under the rules of the China Securities Regulatory Commission and the Shanghai Stock Exchange). The transaction price will be determined based on the prevailing market price at the time of execution.

Gelonghui FinanceJun 2 17:53

Nanmo Biotechnology: First Quarter Report for 2026

SZSIApr 30 00:00 · Announcements

First Quarter Report for 2026

SZSIApr 30 00:00 · Announcements

Nanmo Biotechnology: Summary of the 2025 Annual Report

SZSIApr 27 00:00 · Announcements

Nanmo Biotechnology: 2025 Annual Report

SZSIApr 27 00:00 · Announcements

Summary of the 2025 Annual Report

SZSIApr 27 00:00 · Announcements